Advanced Financial Statements From 2010 to 2026

ADVB Stock   0.30  0.01  2.24%   
Advanced Biomed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Advanced Biomed's valuation are provided below:
Market Capitalization
6.3 M
Earnings Share
(0.17)
We have found one hundred twenty available fundamental signals for Advanced Biomed Common, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Advanced Biomed Common prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.
Check Advanced Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 64.6 K or Interest Income of 64.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0048. Advanced financial statements analysis is a perfect complement when working with Advanced Biomed Valuation or Volatility modules.
  
Build AI portfolio with Advanced Stock
Check out the analysis of Advanced Biomed Correlation against competitors.

Advanced Biomed Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.9 B7.5 B1.3 B
Slightly volatile
Short and Long Term Debt Total1.5 M1.5 M304.3 K
Slightly volatile
Other Current Liabilities3.5 B3.3 B570.8 M
Slightly volatile
Total Current Liabilities3.5 B3.3 B571.2 M
Slightly volatile
Total Stockholder Equity4.2 BB687.8 M
Slightly volatile
Property Plant And Equipment Net79 M75.2 M13.1 M
Slightly volatile
Accounts Payable18.5 K19.5 K122.2 K
Slightly volatile
Cash3.5 B3.3 B574.2 M
Slightly volatile
Non Current Assets Total579.3 M551.7 M95.1 M
Slightly volatile
Cash And Short Term Investments3.5 B3.3 B574.2 M
Slightly volatile
Net Receivables6.8 K7.2 K11.8 K
Pretty Stable
Common Stock Shares Outstanding19.2 M24.9 M14.5 M
Slightly volatile
Liabilities And Stockholders Equity7.9 B7.5 B1.3 B
Slightly volatile
Non Current Liabilities Total175.9 M167.5 M28.8 M
Slightly volatile
Capital Lease Obligations230.5 K145.8 K83 K
Slightly volatile
Other Current Assets3.8 B3.6 B618.5 M
Slightly volatile
Other Stockholder Equity25.8 B24.6 B4.2 B
Slightly volatile
Total Liabilities3.7 B3.5 B599.9 M
Slightly volatile
Net Invested Capital1.5 M1.5 M1.3 M
Slightly volatile
Property Plant And Equipment Gross1.8 M2.2 M1.2 M
Slightly volatile
Total Current Assets7.3 B6.9 B1.2 B
Slightly volatile
Capital Stock30.7 K18 K21.7 K
Slightly volatile
Short Term Debt1.4 M1.3 M255.9 K
Slightly volatile
Common Stock26.1 M24.9 M4.3 M
Slightly volatile
Non Currrent Assets Other500.4 M476.5 M82 M
Slightly volatile
Intangible Assets208 K107.1 K337.2 K
Slightly volatile

Advanced Biomed Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income64.6 K61.5 K15 K
Slightly volatile
Interest Income64.6 K61.5 K15 K
Slightly volatile
Depreciation And Amortization11.7 K12.3 K91.9 K
Pretty Stable
Selling General Administrative2.5 B2.4 B417.2 M
Slightly volatile
Other Operating Expenses80.5 K84.7 K1.7 M
Slightly volatile
Research Development1.1 BB181 M
Slightly volatile
Cost Of Revenue9.2 K12.3 K4.9 K
Slightly volatile
Total Operating Expenses71.3 K75.1 K1.7 M
Slightly volatile
Reconciled Depreciation261.1 K459.5 K155.8 K
Slightly volatile

Advanced Biomed Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow87.8 K92.4 K497.4 K
Slightly volatile
Depreciation11.7 K12.3 K91.9 K
Pretty Stable
Capital Expenditures842886110.7 K
Pretty Stable
Change To Account Receivables64.6 K61.5 K15 K
Slightly volatile
Total Cash From Financing Activities158.1 K166.4 K976.5 K
Very volatile
End Period Cash Flow85 K89.5 K647.8 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio0.00480.00534.4624
Slightly volatile
Book Value Per Share15214526.9719
Slightly volatile
Capex To Depreciation0.00.00.9392
Very volatile
PB Ratio0.00480.00534.4624
Slightly volatile
Payables Turnover0.540.576.8711
Slightly volatile
Cash Per Share12712122.4961
Slightly volatile
Days Payables Outstanding806849K
Slightly volatile
Income Quality0.01.0E-40.2694
Very volatile
Intangibles To Total Assets0.05210.03070.0544
Slightly volatile
Net Debt To EBITDA30.2 K28.8 K5.3 K
Slightly volatile
Current Ratio2.282.421.4619
Slightly volatile
Tangible Book Value Per Share15214526.9691
Slightly volatile
Shareholders Equity Per Share15214526.9719
Slightly volatile
Debt To Equity4.0E-44.0E-40.0283
Slightly volatile
Capex Per Share1.0E-41.0E-40.0077
Pretty Stable
Average Receivables65.2 K73.3 K80 K
Slightly volatile
Interest Debt Per Share0.05520.05260.0133
Slightly volatile
Debt To Assets2.0E-42.0E-40.0136
Pretty Stable
Price Book Value Ratio0.00480.00534.4624
Slightly volatile
Days Of Payables Outstanding806849K
Slightly volatile
Ebt Per Ebit1.341.241.098
Slightly volatile
Company Equity Multiplier1.771.691.4588
Slightly volatile
Long Term Debt To Capitalization0.00.00.0
Slightly volatile
Total Debt To Capitalization4.0E-44.0E-40.0253
Slightly volatile
Debt Equity Ratio4.0E-44.0E-40.0283
Slightly volatile
Quick Ratio2.282.421.4621
Slightly volatile
Cash Ratio1.471.161.9158
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.531.161.186
Slightly volatile
Price To Book Ratio0.00480.00534.4624
Slightly volatile
Debt Ratio2.0E-42.0E-40.0136
Pretty Stable
Price Fair Value0.00480.00534.4624
Slightly volatile

Advanced Biomed Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap12.1 M13.6 M14.9 M
Slightly volatile
Enterprise Value33.4 M37.6 M41 M
Slightly volatile

Advanced Fundamental Market Drivers

About Advanced Biomed Financial Statements

Advanced Biomed stakeholders use historical fundamental indicators, such as Advanced Biomed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Advanced Biomed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Advanced Biomed's assets and liabilities are reflected in the revenues and expenses on Advanced Biomed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Advanced Biomed Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue12.3 K9.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock:
Check out the analysis of Advanced Biomed Correlation against competitors.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.17)
Return On Assets
(0.35)
Return On Equity
(1.65)
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.